North America Cancer Tissue Diagnostics Market to 2027 - Regional Analysis and Forecasts by Test Type (Immunohistochemical Tests and In Situ Hybridization Tests) and Country
Publication Month: Aug 2019
Report Code: TIPRE00006459 No. of Pages: 132 Category: Biotechnology Status: Published
The North America cancer tissue diagnostics market is expected to reach US$ 1,587.38 Mn in 2027 from US$ 923.79 Mn in 2018. The market is estimated to grow with a CAGR of 6.5% from 2019-2027.
The growth of the market is driven by the factors such as, growing cancer prevalence in North American region and new product launches & FDA approvals. However, the market is likely to slower down its growth due to the lack of reimbursement policies for cancer diagnosis in the region.
Frequent FDA approvals and product launches fuel the growth of the market for cancer tissue diagnostics. Most of the major market players are involved in the manufacturing wide range of cancer diagnostics products that offer maximum advantages and early diagnosis. For instance, in June 2019, Agilent Technologies Inc. received the U.S. Food and Drug Administration (FDA) approval for its PD-L1 IHC 22C3 pharmDx assay. The assay is approved to aim in identifying patients with head and neck squamous cell carcinoma (HNSCC) for treatment with KEYTRUDA (pembrolizumab), anti-PD-1 therapy manufactured by Merck. Furthermore, In March 2018, Agilent Technologies Inc. launched a new color for immunohistochemistry: HRP Magenta for Dako Omnis. The latest staining characteristics of the chromogen will help it for the assessment of skin and lung tissue. Thus, the constant developments in technology in diagnostics along with, FDA approvals accelerate the market growth during the forecast period.
US is expected to lead the market in the North America region owing to increasing prevalence of cancer, improved diagnosis and treatment of the condition along with the advancements made by market players. Moreover, the country has several hospitals, super specialty hospitals which offers diagnostic and treatment services for the cardiovascular diseases. Therefore, considering the above mentioned factors the growth of the market in the country is likely to contribute largest share in the North America region during the forecast period.
NORTH AMERICA CANCER TISSUE DIAGNOSTICS – MARKET SEGMENTATION
By Test Type
- Immunohistochemical Tests
- Breast Cancer
- Colorectal Cancer
- Prostate Cancer
- Stomach Cancer
- Others
- In Situ Hybridization Tests
- Breast Cancer
- Lung Cancer
- Bladder Cancer
- Others
Company Profiles
- F. Hoffmann-La Roche Ltd
- Thermo Fisher Scientific Inc.
- Bio Rad Laboratories Inc.
- Abbott
- Enzo Life Sciences, Inc.
- Agilent Technologies, Inc.
- Cancer Genetics Inc.
- Merck KGaA (Sigma-Aldrich Co. LLC)
- Danaher Corporation
- Abcam plc
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
2. North America Cancer Tissue Diagnostics Market – Key Takeaways
3. North America Cancer Tissue Diagnostics Market – Market Landscape
3.1 Overview
3.2 Market Segmentation
3.2.1 North America Cancer Tissue Diagnostics Market – By Test Type
3.2.2 North America Cancer Tissue Diagnostics Market – By Country
3.3 PEST Analysis
4. North America Cancer Tissue Diagnostics Market - Key Market Dynamics
4.1 Key Market Drivers
4.1.1 Growing Cancer Prevalence in North American Region
4.1.2 New Product Launches & FDA Approvals
4.2 Key Market Restraints
4.2.1 Lack of Reimbursement Policies for Cancer Diagnosis
4.3 Key Market Opportunities
4.3.1 Growing Medical Tourism In Mexico
4.4 Future Trends
4.4.1 Inclination Towards Personalized Medicine
4.5 Impact Analysis
5. Cancer Tissue Diagnostics Market – North America Analysis
5.1 North America Cancer Tissue Diagnostics Market Revenue Forecasts And Analysis
5.2 Performance of Key Players
6. North America Cancer Tissue Diagnostics Market Analysis – By Test Type
6.1 Overview
6.2 North America Cancer Tissue Diagnostics Market By Test Type, 2018 & 2027 (%)
6.3 North America Cancer Tissue Diagnostics Market Revenue And Forecasts To 2027, By Test Type (US$ Mn)
6.4 Immunohistochemical Tests Market
6.4.1 Overview
6.4.2 North America Immunohistochemical Tests Market Revenue and Forecasts to 2027 (US$ Mn)
6.4.3 Breast Cancer Market
6.4.3.1 Overview
6.4.3.2 North America Breast Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
6.4.4 Colorectal Cancer Market
6.4.4.1 Overview
6.4.4.2 North America Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
6.4.5 Prostate Cancer Market
6.4.5.1 Overview
6.4.5.2 North America Prostate Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
6.4.6 Stomach Cancer Market
6.4.6.1 Overview
6.4.6.2 North America Stomach Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
6.4.7 Others Market
6.4.7.1 Overview
6.4.7.2 North America Others Market Revenue and Forecasts to 2027 (US$ Mn)
6.5 In Situ Hybridization Tests Market
6.5.1 Overview
6.5.2 North America In Situ Hybridization Tests Market Revenue and Forecasts to 2027 (US$ Mn)
6.5.3 Breast Cancer Market
6.5.3.1 Overview
6.5.3.2 North America Breast Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
6.5.4 Lung Cancer Market
6.5.4.1 Overview
6.5.4.2 North America Lung Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
6.5.5 Bladder Cancer Market
6.5.5.1 Overview
6.5.5.2 North America Bladder Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
6.5.6 Others Market
6.5.6.1 Overview
6.5.6.2 North America Others Market Revenue and Forecasts to 2027 (US$ Mn)
7. North America Cancer Tissue Diagnostics Market Revenue and Forecasts To 2027
7.1 Overview
7.1.1 North America Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
7.1.2 North America Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)
7.1.2.1 North America Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
7.1.2.2 North America In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
7.1.3 North America Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027, By Country (%)
7.2 US Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
7.2.1 US Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
7.2.2 US Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)
7.2.2.1 US Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
7.2.2.2 US In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
7.3 Canada Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
7.3.1 Canada Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
7.3.2 Canada Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)
7.3.2.1 Canada Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
7.3.2.2 Canada In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
7.4 Mexico Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
7.4.1 Mexico Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
7.4.2 Mexico Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)
7.4.2.1 Mexico Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
7.4.2.2 Mexico In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8. Cancer Tissue Diagnostics Market – Industry Landscape
8.1 Overview
8.2 Growth Strategies In The Cancer Tissue Diagnostics Market, 2016-2019
8.3 Organic Growth Strategies
8.3.1 Overview
8.4 Organic Growth Strategies in the Cancer Tissue Diagnostics Market, 2016-2019 (%)
8.4.1 Product Launches
8.4.1.1 Recent Product Launches By Players In The Cancer Tissue Diagnostics Market
8.4.2 Product Approvals
8.4.2.1 Recent Product Approvals By Players In The Cancer Tissue Diagnostics Market
8.4.3 Expansion & Other Activities
8.4.3.1 Recent Expansion & Other Activities By Players In The Cancer Tissue Diagnostics Market
8.4.4 Product Enhancements
8.4.4.1 Recent Product Enhancements By Players In The Cancer Tissue Diagnostics Market
8.5 Inorganic Growth Strategies
8.5.1 Overview
8.6 Inorganic Growth Strategies in the Cancer Tissue Diagnostics Market, 2016-2019 (%)
8.6.1 Agreements
8.6.1.1 Recent Agreements By Players In The Cancer Tissue Diagnostics Market
8.6.2 Partnerships & Collaborations
8.6.2.1 Recent Partnerships & Collaborations By Players In The Cancer Tissue Diagnostics Market
8.6.3 Acquisitions
8.6.3.1 Recent Acquisitions By Players In The Cancer Tissue Diagnostics Market
9. Cancer Tissue Diagnostics Market – Key Company Profiles
9.1 Bio-Rad Laboratories, Inc.
9.1.1 Key Facts
9.1.2 Business Description
9.1.3 Financial Information
9.1.4 Product Portfolio
9.1.5 SWOT Analysis
9.1.6 Key Developments
9.2 Thermo Fisher Scientific, Inc.
9.2.1 Key Facts
9.2.2 Business Description
9.2.3 Financial Information
9.2.4 Product Portfolio
9.2.5 SWOT Analysis
9.2.6 Key Developments
9.3 F. Hoffmann-La Roche Ltd.
9.3.1 Key Facts
9.3.2 Business Description
9.3.3 Financial Overview
9.3.4 Product Portfolio
9.3.5 SWOT Analysis
9.3.6 Key Developments
9.4 Abbott
9.4.1 Key Facts
9.4.2 Business Description
9.4.3 Financial Overview
9.4.4 Product Portfolio
9.4.5 SWOT Analysis
9.4.6 Key Developments
9.5 Enzo Biochem Inc.
9.5.1 Key Facts
9.5.2 Business Description
9.5.3 Financial Overview
9.5.4 Product Portfolio
9.5.5 SWOT Analysis
9.5.6 Key Developments
9.6 Agilent Technologies, Inc.
9.6.1 Key Facts
9.6.2 Business Description
9.6.3 Financial Overview
9.6.4 Product Portfolio
9.6.5 SWOT Analysis
9.6.6 Key Developments
9.7 Cancer Genetics Inc.
9.7.1 Key Facts
9.7.2 Business Description
9.7.3 Financial Overview
9.7.4 Product Portfolio
9.7.5 SWOT Analysis
9.7.6 Key Developments
9.8 Merck Kgaa (Sigma-Aldrich)
9.8.1 Key Facts
9.8.2 Business Description
9.8.3 Financial Overview
9.8.4 Product Portfolio
9.8.5 SWOT Analysis
9.8.6 Key Developments
9.9 Abcam Plc.
9.9.1 Key Facts
9.9.2 Business Description
9.9.3 Financial Overview
9.9.4 Product Portfolio
9.9.5 SWOT Analysis
9.9.6 Key Developments
9.10 Danaher
9.10.1 Key Facts
9.10.2 Business Description
9.10.3 Financial Information
9.10.4 Product Portfolio
9.10.5 SWOT Analysis
9.10.6 Key Developments
10. Appendix
10.1 About The Insight Partners
10.2 Glossary Of Terms
10.3 Methodology
10.3.1 Coverage
10.3.2 Secondary Research
10.3.3 Primary Research
LIST OF TABLES
Table 1. North America Cancer Tissue Diagnostics Market Revenue And Forecasts To 2027, By Test Type (US$ Mn)
Table 2. North America Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)
Table 3. North America Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 4. North America In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 5. US Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)
Table 6. US Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 7. US In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 8. Canada Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)
Table 9. Canada Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 10. Canada In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 11. Mexico Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)
Table 12. Mexico Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 13. Mexico In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 14. Recent Product Launches in the Cancer Tissue Diagnostics Market
Table 15. Recent Product Approvals in the Cancer Tissue Diagnostics Market
Table 16. Recent Expansion & Other Activities By Players In The Cancer Tissue Diagnostics Market
Table 17. Recent Product Enhancements By Players In The Cancer Tissue Diagnostics Market
Table 18. Recent Agreements By Players In The Cancer Tissue Diagnostics Market
Table 19. Recent Partnerships & Collaborations By Players In The Cancer Tissue Diagnostics Market
Table 20. Recent Acquisitions By Players In The Cancer Tissue Diagnostics Market
Table 21. Glossary of Terms, Cancer Tissue Diagnostics Market
LIST OF FIGURES
Figure 1. US Cancer Tissue Diagnostics Market, Revenue (US$ Mn), By Country 2018 & 2027
Figure 2. North America Cancer Tissue Diagnostics Market By Test Type, Market Share (%), 2018
Figure 3. Cancer Tissue Diagnostics Market Segmentation
Figure 4. North America PEST Analysis
Figure 5. Cancer Tissue Diagnostics Market Impact Analysis of Drivers & Restraints
Figure 6. North America Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 7. Prominent Players in the Cancer Tissue Diagnostics Market
Figure 8. North America Cancer Tissue Diagnostics Market, By Test Type 2018 & 2027 (%)
Figure 9. North America Immunohistochemical Tests Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 10. North America Breast Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 11. North America Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 12. North America Prostate Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 13. North America Stomach Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 14. North America Others Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 15. North America In Situ Hybridization Tests Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 16. North America Breast Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 17. North America Lung Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 18. North America Bladder Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 19. North America Others Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 20. North America Cancer Tissue Diagnostics Market Revenue Overview, by Country, 2018 (US$ Mn)
Figure 21. North America Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 22. North America Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027, By Country (%)
Figure 23. US Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 24. Canada Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 25. Mexico Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 26. Growth Strategies in the Cancer Tissue Diagnostics Market, 2016-2019
Figure 27. Organic Growth Strategies in the Cancer Tissue Diagnostics Market, 2016-2019 (%)
Figure 28. Inorganic Developments in the Cancer Tissue Diagnostics Market, 2016-2019(%)
The List of Companies
- F. Hoffmann-La Roche Ltd
- Thermo Fisher Scientific Inc.
- Bio Rad Laboratories Inc.
- Abbott
- Enzo Life Sciences, Inc.
- Agilent Technologies, Inc.
- Cancer Genetics Inc.
- Merck KGaA (Sigma-Aldrich Co. LLC)
- Danaher Corporation
- Abcam plc